Crescita Therpeutc (TSE:CTX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Crescita Therapeutics has successfully concluded its Annual General and Special Meeting, with overwhelming shareholder support for the election of its director nominees and the reappointment of Ernst & Young LLP as external auditors. Shareholders also approved the continuation of the company’s Share Incentive Plan, endorsing the current strategic direction of the Canadian commercial dermatology firm.
For further insights into TSE:CTX stock, check out TipRanks’ Stock Analysis page.